2 research outputs found

    PRANIC HEALING: A STRESS BUSTER FOR CANCER PATIENTS.

    Get PDF
    Pranic healing is a highly developed and tested system of energy based healing techniques that utilizes \"Prana\" to balance harmonize and transform the body\'s energy processes. \"Prana\" is a Sanskrit word that means \"Life-force\" This invisible bio-energy or vital energy keeps the body alive and maintains a state of good health. In acupuncture, the Chinese refer to this subtle energy as \"Chi\". It is also called \"Ruah\" or the \"Breath of life\" in the old testament. Pranic healing is a simple yet powerful and effective no touch energy healing. It is based on the fundamental principle that the body is a \"Self-repairing\" living entity that possesses the innate ability to heal itself. Pranic healing works on the principle that the healing process is accelerated by increasing the life force or vital energy on the affected part of the physical body. Pranic healing influences this natural life force to being about a healthier physical body. Pranic healing is applied on the bio-electromagnetic field known as the aura, which contains the mold and blueprint of the physical body. This bioplasmic body absorbs life energy and distributes it to the organs and glands. Disease first appear as energetic disruption in the energy field before manifesting as ailments in the physical body. With all diseases including cancer the first objective is to understand that the cause is thoughts one\'s own guilt or harmful thoughts and feeling created by one\'s upon himself. To heal from cancer one must fully cleanse the physical, emotional and mental layers of body system

    ANTI TUBERCULAR DRUGS INDUCED HEPATOTOXICITY IN A NEW TERTIARY CARE HOSPITAL OF A TRIBAL DISTRICT OF ODISHA

    Get PDF
    Objective: India accounts for about one-fourth of the global TB burden. WHO TB statistics for India for 2018 gives an estimated incidence fig. of 2.69 million cases (199 per one lakh population). Drug-induced Hepatotoxicity is responsible for significant morbidity and mortality of the TB patient if these drugs continued after symptoms of hepatotoxicity develop. Whether the hepatotoxicity is due to individual drugs or due to additive effects is still unclear. The management therapy for TB patients with anti-TB DIH is imperative to ensure successful TB treatment and not recurrence DIH. Aim of the current study is to find out the pattern of Liver enzyme raised after antitubercular therapy in the tribal population of Koraput district where different phylogenetic populations reside where clinically it was observed by the physician little early onset of hepatotoxicity than national and international data. Methods: A prospective study was done after clearance from the Institutional Ethical Committee, Saheed Laxman Nayak Medical College, Koraput, from January 2019 to December 2019. Patients with>15 y of age with pulmonary and extrapulmonary tuberculosis with normal liver enzymes were included. Patients having abnormal liver enzymes before treatment, seropositive TB patients with human immunodeficiency virus infection, pregnant ladies and children<15 y of age were excluded. Results: Out of 922 patients in total; 4.78% (44) tuberculosis patients developed anti TB DIH. 68.18% (30) patients are below 50 y of age and 31.82% (14) are above 50 y of age group among TB patients with DIH. Age has no statistically significant influence on the occurrence of anti-TB DIH, but there is a statistically significant influence of sex on the occurrence of anti TB DIH. The mean occurrence of anti TB DIH is 18±18.16 d. One case of anti TB DIH patients shows signs and symptoms as early as on day 6th. The commonest symptoms are nausea and vomiting in 64% of patients who developed DIH. Interruption of ATT after DIH occurred in 79.54% of patients with recurrence in only 9.9% of patients after the reintroduction of ATT. Conclusion: Anti TB DIH mostly occurred between 7-28 d of starting the ATT in this geographical region. The duration of the anti TB ATT regimen is prolonged due to DIH. We recommend that all patients should have LTs 2 w after starting ATT, even if asymptomatic
    corecore